¼¼°èÀÇ ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå Á¶»ç º¸°í¼ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2023-2030³â)
Global Healthcare Analytical Testing Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â Á¶»ç ±â°£ÀÎ 2023-2030³â CAGR 10.42%·Î, 2022³â 139¾ï 4,000¸¸ ´Þ·¯¿¡¼ 2030³â¿¡´Â 340¾ï 2,000¸¸ ´Þ·¯ °¡±î¿î ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º´Â ¹ÙÀÌ¿À ÀǾàǰ, Á¦¾à ¹× ÀÇ·á±â±â Á¦Á¶¾÷ü°¡ ÀǾàǰ °³¹ß ÇÁ·Î¼¼½º¸¦ Áö¿øÇϱâ À§ÇØ ÀÚÁÖ ÀÌ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¼ºñ½º´Â ½Å¾à °³¹ß¿¡¼ ÀÓ»ó °³¹ß ¹× ÀÓ»ó½ÃÇèÀ» °ÅÃÄ ÆÇ¸Å¿¡ À̸£±â±îÁö ÇÁ·Î¼¼½º¸¦ Áö¿øÇÕ´Ï´Ù. Àç·á Å×½ºÆ®´Â ¶ÇÇÑ ÇコÄɾ¼ »ç¿ëµÇ´Â ºÐ¼® Å×½ºÆ® ¼ºñ½º¸¦ ¼³¸íÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÇコÄÉ¾î »ê¾÷À» À§ÇÑ ºÐ¼® ¼ºñ½º´Â Á¦Ç°ÀÇ Ç°Áú°ú ¼øµµ¸¦ È®ÀÎÇϱâ À§ÇØ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ Á¦Á¶ Áß ¶Ç´Â Á¦Ç° °³¹ß Ãʱ⠴ܰ迡¼ ǰ¸ñÀ» ¿À¿°½Ãų ¼ö ÀÖ´Â ¿ä¼Ò¸¦ °Ë»çÇÕ´Ï´Ù. ¿¹¸¦ µé¾î ºÐ¼® Å×½ºÆ® Àåºñ´Â »ý¹°ÇÐÀû ¸ÅÆ®¸¯½º¿¡¼ ÀǾàǰ°ú ±× ´ë»ç »ê¹°À» ½Äº°ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù.
½ÃÀå ¿ªÇÐ :
½ÃÀå °³Ã´ ºñ¿ëÀ» Àý°¨Çϰí Ä¡·á ½Çü¸¦ È¿À²ÀûÀ¸·Î Æò°¡ÇÔÀ¸·Î½á ºñ¿ë È¿À²ÀûÀÎ ÀǾàǰ °³¹ß Áֱ⸦ ½ÇÇöÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¦¾à ¹× ¹ÙÀÌ¿À Á¦¾à »ê¾÷Àº ´õ ³ªÀº ½Å¾à ¿¬±¸°³¹ß(R&D)¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½ºÀÇ ³ôÀº ºñ¿ë°ú ½ÅÈï ½ÃÀå¿¡¼ÀÇ ³·Àº ¼ö¿ë·ü·Î ÀÎÇØ ½ÃÀå ¼ºÀå ¼Óµµ´Â Á¦ÇÑÀûÀÔ´Ï´Ù. ¶ÇÇÑ ³ôÀº Àåºñ ¹× À¯Áöº¸¼ö ºñ¿ë, ½Ã¾à »ç¿ë¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¤, ÀÚ°ÝÁõÀ» ¼ÒÁöÇÑ Àη ºÎÁ· µîÀº ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½ºÀÇ È®ÀåÀ» ÀúÇØÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Á¶»ç º¸°í¼´Â Portre's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ÅøÀº ¼¼°è ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀåÀÇ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ºÐ¼® Å×½ºÆ® ¼ºñ½º »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.
Áö¿ªº° ºÐ¼® :
ÀÌ ¼½¼Ç¿¡¼´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀåÀÇ ÇöÀç¿Í ¹Ì·¡ ¼ö¿ä¸¦ °Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.
¸ÂÃãÇü ¿ä±¸»çÇ×ÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. ¸®¼Ä¡ÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå ÇÏÀ̶óÀÌÆ®
- ¼¼°è ½ÃÀå ½º³À¼ô
Á¦3Àå ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º - »ê¾÷ ºÐ¼®
- ¼·Ð : ½ÃÀå ¿ªÇÐ
- ½ÃÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¾ïÁ¦¿äÀÎ
- ½ÃÀå ±âȸ
- ¾÷°è µ¿Çâ
- Porter's Five Forces ºÐ¼®
- ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®
- ¹ë·ùüÀÎ ºÐ¼®
- ¿øÀç·á ºÐ¼®
- ¿øÀç·á ¸®½ºÆ®
- ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
- ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
- ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
- ¸¶ÄÉÆÃ Ã¤³Î
- ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
- ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
- ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ
Á¦5Àå COVID-19 ¹ß»ýÀÇ ¿µÇ⠺м®
Á¦6Àå ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå ºÐ¼® : À¯Çüº°
- À¯Çüº° °³¿ä
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- À¯Çüº° ºÐ¼®
- ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¼ºñ½º
- ÀǾàǰ ºÐ¼® ½ÃÇè ¼ºñ½º
Á¦7Àå ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀå ºÐ¼® : Áö¿ªº°
- Áö¿ªº° Àü¸Á
- ¼·Ð
- ºÏ¹Ì ÆÇ¸Å ºÐ¼®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ºÏ¹Ì : ºÎ¹®º°
- ºÏ¹Ì : ±¹°¡º°
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´ ÆÇ¸Å ºÐ¼®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- À¯·´ : ºÎ¹®º°
- À¯·´ : ±¹°¡º°
- ¿µ±¹
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- È£ÁÖ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
- ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- Æä·ç
- Ä¥·¹
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- À̽º¶ó¿¤
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦8Àå ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º ±â¾÷ÀÇ °æÀï ±¸µµ
- ÇコÄÉ¾î ºÐ¼® ½ÃÇè ¼ºñ½º ½ÃÀåÀÇ °æÀï
- Á¦ÈÞ/Çù·Â/ÇÕÀÇ
- ÇÕº´¡¤Àμö
- ½ÅÁ¦Ç° ¹ß¸Å
- ±âŸ °³¹ß
Á¦9Àå ±â¾÷ °³¿ä
- »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
- ½ÃÀå ÁýÁßµµ
- PPD Inc.
- ICON plc
- LabCorp
- Charles River Laboratories International Inc.
- Syneos Health
- SGS SA
- Eurofins Scientific
- Pace Analytical Services LLC
- Toxikon Inc.
- Intertek Group
KSA
The global demand for Healthcare Analytical Testing Services Market is presumed to reach the market size of nearly USD 34.02 BN by 2030 from USD 13.94 BN in 2022 with a CAGR of 10.42% under the study period 2023 - 2030.
Healthcare analytical testing services are frequently used by biopharmaceutical, pharmaceutical, and medical device manufacturers to support them during the drug development process. From medication discovery through clinical development or clinical trials to marketing, the service assists in the process. Material testing is also used to describe analytical testing services used in healthcare. Analytical services for the healthcare industry are required to verify product quality and purity. In addition, it inspects for elements that could contaminate the items throughout production or the early stages of product development. For example, devices for analytical testing are used to identify pharmaceuticals and their metabolites in biological matrices.
MARKET DYNAMICS:
Among the key reasons propelling the market expansion is the increasing demand for healthcare analytical testing services owing to its benefits, including utility in reducing the cost of drug development and efficiently assessing the therapeutic entity, resulting in a cost-effective drug development cycle. The pharmaceutical and biopharmaceutical industries are investing a lot in research and development (R&D) for new and better treatments to help grow the market for healthcare analytical testing services. However, the market's growth pace would be restricted by the high cost of healthcare analytical testing services and the low acceptance rate in developing and emerging nations. In addition, because of costly equipment and maintenance costs, strict rules on reagent usage, and a shortage of qualified personnel are some significant issues that are anticipated to hinder the expansion of healthcare analytical testing services.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of healthcare analytical testing services. The growth and trends of healthcare analytical testing services industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the healthcare analytical testing services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Medical Device Analytical Testing Services (Extractable & Leachable, Material Characterization, Physical Testing, Bioburden Testing, Sterility Testing, Other Tests)
- Pharmaceutical Analytical Testing Services (Bioanalytical Testing, Method Development & Validation, Stability Testing, Other Testing Services)
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Healthcare Analytical Testing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the healthcare analytical testing services market include PPD Inc., ICON plc, LabCorp, Charles River Laboratories International Inc., Syneos Health, SGS SA, Eurofins Scientific, Pace Analytical Services LLC, Toxikon Inc., Intertek Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . HEALTHCARE ANALYTICAL TESTING SERVICES - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET ANALYSIS BY TYPE
- 6.1 Overview by Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Type
- 6.4 Medical Device Analytical Testing Services Historic and Forecast Sales by Regions
- 6.5 Pharmaceutical Analytical Testing Services Historic and Forecast Sales by Regions
7 . GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET ANALYSIS BY GEOGRAPHY
- 7.1. Regional Outlook
- 7.2. Introduction
- 7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
- 7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
- 7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. Rest Of Asia Pacific Sales Analysis
- 7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
- 7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis
8 . COMPETITIVE LANDSCAPE OF THE HEALTHCARE ANALYTICAL TESTING SERVICES COMPANIES
- 8.1. Healthcare Analytical Testing Services Market Competition
- 8.2. Partnership/Collaboration/Agreement
- 8.3. Merger And Acquisitions
- 8.4. New Product Launch
- 8.5. Other Developments
9 . COMPANY PROFILES OF HEALTHCARE ANALYTICAL TESTING SERVICES INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Market Concentration Rate
- 9.3. PPD Inc.
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
- 9.4. ICON plc
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
- 9.5. LabCorp
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
- 9.6. Charles River Laboratories International Inc.
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
- 9.7. Syneos Health
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
- 9.8. SGS SA
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
- 9.9. Eurofins Scientific
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
- 9.10. Pace Analytical Services LLC
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
- 9.11. Toxikon Inc.
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments
- 9.12. Intertek Group
- 9.12.1. Company Overview
- 9.12.2. Company Revenue
- 9.12.3. Products
- 9.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies